SAMSRITA LABS LIMITED Share Price

Samsrita Labs Limited is an India-based biopharma company. The Company is engaged in activities, such as trading, exports and imports, manufacturing of bulk drugs, research, and development (R&D) through joint ventures or associations or mergers or by its own. It has established platforms in the areas of stem cell research and therapy, new drug discovery, molecular prognosis and diagnostics services, CRO, stem cell focused super specialty hospital, RNA interference technology, and medical devices. Its Stem Cell R&D division specializes in stem cell research and therapy, regenerative medicine, bio-artificial organ scaffolds development, nanobiotechnology, nanoformulation of cancer drugs, molecular genetics and molecular virology, stem cell, and cord blood banking. Its Molecular Prognosis and Diagnostics services division provides molecular diagnostics and services in the areas of cytogenetics, pharmacogenomics, pathology, radiology, hematology, biochemistry, and microbiology.As of 26 May 2026, SAMSRITA LABS LIMITED share price is ₹15.52. The stock opened at ₹15.45, compared to its previous close of ₹16.25. During today's trading session, SAMSRITA LABS LIMITED share price moved in the range of ₹15.44 to ₹15.52, with an average price of ₹15.48 for the day. Looking at its last 52-week, the stock has touched a low of ₹15.44 and a high of ₹15.52.

The market capitalization of SAMSRITA LABS LIMITED is ₹37 Crs, with a P/E ratio of -4.9 and a dividend yield of 0.00%.